Temozolomide
- Product NDC
- 50268-761
- 11-digit product format
- 502680761
- Labeler code
- 50268
- Product ID
- 50268-761_ed872311-129b-1fc7-e053-2a95a90a19e3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Temozolomide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA203691
- Marketing category
- ANDA
- Marketing start
- 2017-03-23
- Marketing end
- 0000-00-00
- Substance
- TEMOZOLOMIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Alkylating Activity [MoA], Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50268-761 | TEMOZOLOMIDE CAPSULE [AVPAK] | 6 | Legacy NDC | 20240110_36563b1d-61f2-43e5-b7c1-c6d9036ef28b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-761-12 | 50268076112 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-761-12) > 1 CAPSULE in 1 BLISTER PACK (50268-761-11) | 20 blister pack | 2017-03-23 | 0000-00-00 | No | No | Current |